Clinic
Caribbean Wellness Oncology, PSC
Caribbean Wellness Oncology, PSC was paid $3.55M by Medicaid between May 2018 and Dec 2024, across 24 billing codes. Its largest line is Q0084, Chemotherapy administration by infusion technique only, per visit — 31% of everything it billed.
33Billing provider infoCARIBBEAN WELLNESS ONCOLOGY, PSC
PONCE, PR 00717
PONCE, PR 00717
33aNPI1811419575assigned 07/13/2017
33bProvider typeOncology Clinic/Center
28Total paid$3.55M
24GClaims50,719
24DCodes billed24
24AFirst – last monthMay 2018 – Dec 2024
Compared with peers
Next to other Oncology Clinic/Center providers in Puerto Rico
Rank by total paid#2 of 21
Median peer was paid$255K
This provider vs. median14×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,141 | $116K | |
| 2019 | 6,398 | $439K | |
| 2020 | 7,426 | $493K | |
| 2021 | 5,686 | $405K | |
| 2022 | 6,700 | $419K | |
| 2023 | 10,150 | $868K | |
| 2024incomplete | 11,218 | $809K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| Q0084 | Chemotherapy administration by infusion technique only, per visit | 31% | 12,546 | 5,225 | $1.11M |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 21% | 9,157 | 4,477 | $742K |
| 96415 | 12% | 6,101 | 3,208 | $412K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 8.0% | 3,901 | 3,628 | $284K |
| 96417 | 6.5% | 3,965 | 2,521 | $231K | |
| J9035 | Injection, bevacizumab, 10 mg | 5.8% | 44 | 25 | $207K |
| J9171 | Injection, docetaxel, 1 mg | 5.0% | 67 | 52 | $179K |
| 96367 | 2.0% | 3,634 | 2,007 | $72K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.8% | 1,405 | 825 | $65K |
| 96416 | 1.7% | 822 | 522 | $61K | |
| 96402 | <1% | 1,301 | 1,177 | $34K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 403 | 322 | $32K |
12 more codes
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | <1% | 172 | $27K |
| J1453 | Injection, fosaprepitant, 1 mg | <1% | 97 | $20K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,647 | $18K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 641 | $13K |
| J9045 | Injection, carboplatin, 50 mg | <1% | 192 | $12K |
| 96523 | <1% | 567 | $10K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,489 | $7K |
| J3489 | Injection, zoledronic acid, 1 mg | <1% | 118 | $7K |
| J9190 | Injection, fluorouracil, 500 mg | <1% | 285 | $6K |
| J0640 | Injection, leucovorin calcium, per 50 mg | <1% | 125 | $4K |
| J2916 | Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg | <1% | 28 | $1K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 12 | $886.56 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCRUZ, ERICK (PRESIDENT)